RIC3 acetylcholine receptor chaperone (RIC3)

RIC3 acetylcholine receptor chaperone is a type I transmembrane chaperone protein localized primarily in the endoplasmic reticulum, where it binds to unfolded and partially assembled subunits of specific nicotinic acetylcholine receptors (notably α7, α8, α3β2, α3β4, α4β2, α4β4) as well as 5-HT3 serotonin receptors, stabilizing, folding, and promoting their assembly and trafficking to the cell surface for functional expression[1][2][3]. The protein consists of an N-terminal transmembrane domain, a proline-rich spacer, and a cytosolic C-terminal coiled-coil domain, exhibiting high specificity in chaperone activity for ligand-gated ion channels related to acetylcholine signaling[2][3]. RIC3 has been implicated in the genetic risk of Parkinson’s disease, retinal dystrophy, and may play roles in other neurologic and inflammatory conditions[2][5]. Its modulatory effects are context-dependent (cellular environment, isoform, and target), which presents challenges for therapeutic intervention[5]. As a chaperone, it is not a classical receptor or enzyme drug target, but its role in receptor biogenesis makes it a candidate for pharmacological modulation of cholinergic signaling.

Other names

Protein RIC-3RIC3UNQ720/PRO1385FLJ11608PRO1385AYST720Resistant to inhibitor of cholinesterase 3RIC-3resistance to inhibitors of cholinesterase 3resistance to inhibitors of cholinesterase 3-like protein

Facilitates folding and assembly of α7 and other nicotinic acetylcholine receptor subunits. Promotes surface expression of functional receptors. May modulate maturation of 5-HT3 serotonin receptors.